The latest price target for Envoy Medical (NASDAQ:COCH) was reported by Ascendiant Capital on June 24, 2024. The analyst firm set a price target for $8.50 expecting COCH to rise to within 12 months (a possible 191.10% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Envoy Medical (NASDAQ:COCH) was provided by Ascendiant Capital, and Envoy Medical initiated their buy rating.

There is no last upgrade for Envoy Medical

There is no last downgrade for Envoy Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Envoy Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Envoy Medical was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.

While ratings are subjective and will change, the latest Envoy Medical (COCH) rating was a initiated with a price target of $0.00 to $8.50. The current price Envoy Medical (COCH) is trading at is $2.92, which is within the analyst’s predicted range.